Clinical evidence for neuroprotection in glaucoma.
作者信息
Cordeiro M Francesca, Levin Leonard A
出版信息
Am J Ophthalmol. 2011 Nov;152(5):715-6. doi: 10.1016/j.ajo.2011.06.015.
Abstract
摘要
相似文献
1
Clinical evidence for neuroprotection in glaucoma.青光眼神经保护的临床证据。
Am J Ophthalmol. 2011 Nov;152(5):715-6. doi: 10.1016/j.ajo.2011.06.015.
2
A randomized trial of brimonidine versus timolol in preserving visual function: results from the Low-pressure Glaucoma Treatment Study.溴莫尼定与噻吗洛尔在保护视功能方面的随机试验：低压青光眼治疗研究结果
Am J Ophthalmol. 2011 Nov;152(5):877; author reply 877-8. doi: 10.1016/j.ajo.2011.07.009.
3
The rate of progression and ocular perfusion pressure in the Low-pressure Glaucoma Treatment Study.低压性青光眼治疗研究中的疾病进展率和眼灌注压
Am J Ophthalmol. 2011 Nov;152(5):880; author reply 880-1. doi: 10.1016/j.ajo.2011.06.019.
4
A randomized trial of brimonidine versus timolol in preserving visual function: results from the Low-Pressure Glaucoma Treatment Study.一项关于溴莫尼定与噻吗洛尔对视功能保护作用的随机试验：来自低眼压性青光眼治疗研究的结果。
Am J Ophthalmol. 2011 Apr;151(4):671-81. doi: 10.1016/j.ajo.2010.09.026. Epub 2011 Jan 22.
5
Risk factors for visual field progression in the low-pressure glaucoma treatment study.低眼压性青光眼治疗研究中视野进展的风险因素。
Am J Ophthalmol. 2012 Oct;154(4):702-11. doi: 10.1016/j.ajo.2012.04.015. Epub 2012 Jul 25.
6
Special considerations in low-tension glaucoma.低眼压性青光眼的特殊考量
Can J Ophthalmol. 2007 Jun;42(3):414-7.
7
Pressure or progression?
Arch Ophthalmol. 1999 Mar;117(3):417-9.
8
Normal-tension glaucoma.
Ophthalmology. 2008 Mar;115(3):590-1; author reply 591-2. doi: 10.1016/j.ophtha.2007.08.017.
9
Ulcerated infantile hemangioma: novel treatment with topical brimonidine-timolol.溃疡型婴儿血管瘤：溴莫尼定-噻吗洛尔局部用药的新疗法
Pediatr Dermatol. 2014 Nov-Dec;31(6):754-6. doi: 10.1111/pde.12420.
10
Effect of brimonidine on retinal vascular autoregulation and short-term visual function in normal tension glaucoma.溴莫尼定对正常眼压性青光眼视网膜血管自动调节和短期视力的影响。
Am J Ophthalmol. 2014 Jul;158(1):105-112.e1. doi: 10.1016/j.ajo.2014.03.015. Epub 2014 Apr 5.
引用本文的文献
1
Neuroprotective Activity of Rasayana Formulation and Effect of Shigru Pallava Eye Drops on Intraocular Pressure as an Add-on Therapy Compared to the Standard of Care in Primary Open-Angle Glaucoma: Protocol for an Exploratory, Open-label, Two-arm Randomized Controlled Trial.Rasayana配方的神经保护活性以及Shigru Pallava眼药水作为原发性开角型青光眼附加治疗对眼压的影响：一项探索性、开放标签、双臂随机对照试验方案。
F1000Res. 2025 Apr 22;14:454. doi: 10.12688/f1000research.163722.1. eCollection 2025.
2
Neuroprotection in neurodegenerations of the brain and eye: Lessons from the past and directions for the future.大脑和眼部神经退行性疾病中的神经保护：过去的经验与未来的方向
Front Neurol. 2022 Aug 12;13:964197. doi: 10.3389/fneur.2022.964197. eCollection 2022.
3
An Innovative In Vitro Open-Angle Glaucoma Model (IVOM) Shows Changes Induced by Increased Ocular Pressure and Oxidative Stress.一种创新性的体外开角型青光眼模型（IVOM）显示出眼压升高和氧化应激诱导的变化。
Int J Mol Sci. 2021 Nov 9;22(22):12129. doi: 10.3390/ijms222212129.
4
Activation of adenosine A receptor protects retinal ganglion cells from degeneration induced by ocular hypertension.腺苷 A 受体的激活可保护视网膜神经节细胞免受高眼压诱导的变性。
Cell Death Dis. 2020 May 27;11(5):401. doi: 10.1038/s41419-020-2593-y.
5
Microglia in Retinal Degeneration.视网膜变性中的小胶质细胞。
Front Immunol. 2019 Aug 20;10:1975. doi: 10.3389/fimmu.2019.01975. eCollection 2019.
6
High hydrostatic pressure induces apoptosis of retinal ganglion cells via regulation of the NGF signalling pathway.高静压通过调节 NGF 信号通路诱导视网膜神经节细胞凋亡。
Mol Med Rep. 2019 Jun;19(6):5321-5334. doi: 10.3892/mmr.2019.10206. Epub 2019 Apr 30.
7
European Glaucoma Society Terminology and Guidelines for Glaucoma, 4th Edition - Chapter 3: Treatment principles and options Supported by the EGS Foundation: Part 1: Foreword; Introduction; Glossary; Chapter 3 Treatment principles and options.《欧洲青光眼协会青光眼术语与指南》第4版 - 第3章：治疗原则与选择 由欧洲青光眼协会基金会支持：第1部分：前言；引言；术语表；第3章治疗原则与选择
Br J Ophthalmol. 2017 Jun;101(6):130-195. doi: 10.1136/bjophthalmol-2016-EGSguideline.003.
8
Neuroprotection for treatment of glaucoma in adults.用于治疗成人青光眼的神经保护。
Cochrane Database Syst Rev. 2017 Jan 25;1(1):CD006539. doi: 10.1002/14651858.CD006539.pub4.
9
Caffeine administration prevents retinal neuroinflammation and loss of retinal ganglion cells in an animal model of glaucoma.在青光眼动物模型中，给予咖啡因可预防视网膜神经炎症和视网膜神经节细胞的丧失。
Sci Rep. 2016 Jun 8;6:27532. doi: 10.1038/srep27532.
10
Adenosine A2AR blockade prevents neuroinflammation-induced death of retinal ganglion cells caused by elevated pressure.腺苷A2A受体阻断可预防压力升高引起的神经炎症诱导的视网膜神经节细胞死亡。
J Neuroinflammation. 2015 Jun 10;12:115. doi: 10.1186/s12974-015-0333-5.
本文引用的文献
1
A randomized trial of brimonidine versus timolol in preserving visual function: results from the Low-Pressure Glaucoma Treatment Study.一项关于溴莫尼定与噻吗洛尔对视功能保护作用的随机试验：来自低眼压性青光眼治疗研究的结果。
Am J Ophthalmol. 2011 Apr;151(4):671-81. doi: 10.1016/j.ajo.2010.09.026. Epub 2011 Jan 22.
2
Neuroprotection in glaucoma - Is there a future role?青光眼的神经保护治疗——是否有未来的作用？
Exp Eye Res. 2010 Nov;91(5):554-66. doi: 10.1016/j.exer.2010.08.009. Epub 2010 Aug 26.
3
Diurnal and nocturnal effects of brimonidine monotherapy on intraocular pressure.溴莫尼定单药治疗对眼压的昼夜影响。
Ophthalmology. 2010 Nov;117(11):2075-9. doi: 10.1016/j.ophtha.2010.03.026. Epub 2010 Jul 21.
4
Lost in translation: bumps in the road between bench and bedside.翻译之困：基础研究与临床应用之间的障碍
JAMA. 2010 Apr 21;303(15):1533-4. doi: 10.1001/jama.2010.463.
5
Neuroprotection for treatment of glaucoma in adults.用于治疗成人青光眼的神经保护。
Cochrane Database Syst Rev. 2010 Feb 17(2):CD006539. doi: 10.1002/14651858.CD006539.pub2.
6
Neuroprotection: extrapolating from neurologic diseases to the eye.神经保护：从神经系统疾病推断至眼部疾病
Am J Ophthalmol. 2009 Aug;148(2):186-191.e2. doi: 10.1016/j.ajo.2009.03.029. Epub 2009 May 23.
7
Effects of topical hypotensive drugs on circadian IOP, blood pressure, and calculated diastolic ocular perfusion pressure in patients with glaucoma.局部降压药物对青光眼患者昼夜眼压、血压及计算得出的舒张期眼灌注压的影响。
Invest Ophthalmol Vis Sci. 2006 Jul;47(7):2917-23. doi: 10.1167/iovs.05-1253.
8
Comparison of glaucomatous progression between untreated patients with normal-tension glaucoma and patients with therapeutically reduced intraocular pressures. Collaborative Normal-Tension Glaucoma Study Group.未经治疗的正常眼压性青光眼患者与经治疗眼压降低的患者之间青光眼进展情况的比较。协作性正常眼压性青光眼研究组。
Am J Ophthalmol. 1998 Oct;126(4):487-97. doi: 10.1016/s0002-9394(98)00223-2.
Zotero 插件